Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Chocolate-Flavored Dr. Cocoa™ for Children, A Patented OTC Cough/Cold Line, Fights the Cold Symptoms, Not the Child
  • USA - English


News provided by

Robin Leedy & Associates

Jan 12, 2015, 09:30 ET

Share this article

Share toX

Share this article

Share toX

Dr. Cocoa for Children Cough and Cold Medicines
Dr. Cocoa for Children Cough and Cold Medicines

WESTPORT, CT (PRWEB) January 12, 2015 -- In a new national survey(1) of U.S. parents of school-age children (ages 4-13), almost 40% report that it isn’t always easy to give their children over-the-counter liquid cough/cold medicines. One-third of parents (34%) believe the taste of the medicine impacts how easy it is to give their child the recommended dose, with one in four (24%) saying their child often complains that liquid medicines taste bad. Like these parents, infirst Healthcare knows that taste matters, so they are providing a new solution with the new Dr. Cocoa™ for Children brand. It’s the first-ever line of patented over-the-counter cough and cold medicines formulated with trusted, effective ingredients and 10% real cocoa for real chocolate taste to improve compliance.

“Our mission is to make known, safe and effective medicines better. With Dr. Cocoa we are making effective cough and cold medicines better for kids and their parents with real chocolate flavor,” says James Barickman, General Manager at infirst Healthcare USA. “Taste is important to compliance among children, and many parents struggle with getting their children to take medicine as directed. Dr. Cocoa’s soothing real-cocoa formula was developed to improve on this issue among children – it triggers a smile, not a struggle.”

A clinical palatability study among 50 pediatric patients showed that on average the taste of Dr. Cocoa was rated as good(2). “The pediatric participants confirmed that the taste is good and hence, is not a compliance barrier. Purposefully the product is not designed to be perceived as ‘really good’ as flavor should support compliance but for a medicine not be exceedingly appealing,” adds Barickman.

Dye-, alcohol- and gluten-free, the new Dr. Cocoa™ line is available in three formulas that combine trusted, effective ingredients with 10% real cocoa for a real chocolate flavor:
• Dr. Cocoa™ for Children Long-Acting Cough Relief is for the non-drowsy, temporary relief of coughing due to minor throat and bronchial irritations as may occur with a cold. Intended for use in children ages 4 -13. Carefully follow the instructions for dosing on the box using the enclosed measuring spoon. (Active ingredient: Dextromethorphan)
• Dr. Cocoa™ for Children Daytime Cough+Cold Relief is for the non-drowsy, temporary relief of cough due to minor throat and bronchial irritation as may occur with a cold, along with nasal congestion. Indicated for use in children ages 4-13; use in children under the age of 6 should be on the advice of a doctor. Carefully follow the instructions for dosing on the box using the enclosed measuring spoon. (Active ingredients: Dextromethorphan, Phenylephrine)
• Dr. Cocoa™ for Children Nighttime Cough+Cold Relief temporarily relieves sneezing, itchy nose or throat, cough due to minor throat and bronchial irritation as may occur with a cold, nasal congestion, runny nose, and itchy, watery eyes, while helping your child to rest. Intended for use in children ages 6-13. Carefully follow the instructions for dosing on the box using the enclosed measuring spoon. (Active ingredients: Diphenhydramine, Phenylephrine)

Dr. Cocoa™ for Children is available online at drugstore.com and available on shelves at all major food, drug, and mass merchant retailers nationwide. For more information, visit http://www.drcocoa.com, or to connect with the brand, visit http://www.facebook.com/DrCocoaforChildren.

Dr. Cocoa™ for Children is owned and distributed by infirst Healthcare Inc., a subsidiary of U.K.-based infirst Healthcare Ltd., a company determined to bring meaningful innovation for everyday ailments to consumer healthcare and primary care practitioners. infirst Healthcare believes that more effective treatments can be found by taking known drugs and making them better to increase patient compliance and improve outcomes.

*Although Dr. Cocoa™ tastes good, it is an FDA-regulated medicine. Use as directed, and keep this and all medicines safely out of the reach of children. For specific questions about dosing or formulations, please speak with a pediatrician.

(1)Survey was conducted online within the United States between May 2-6, 2014 among 2,049 adults aged 18 and older, of whom 293 are parents of children age 4-13, by Harris Poll on behalf of infirst Healthcare via its Quick Query omnibus product. Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was used to adjust for respondents’ propensity to be online.

(2)Taste rated on a 5 point scale, [1= really bad, 2=bad, 3=not sure, 4=good, 5=really good]. Dr. Cocoa achieved a mean rating of 4.14. Pediatric Taste Study (2013); conducted among 50 patients, ages 6-13; 8-hour cough formulation tested. Clinical Study Administrators: Radian Research, Pinellas Park, FL; Methodology: “The Standard Guide for Sensory Evaluations of Products by Children”; ASTM Designation: E2299-11

Alexandra Tockstein, Robin Leedy & Associates, http://rlapr.com/, +1 (914) 241-0086 Ext: 11, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.